Verified Nov 2026
Other
·

Milan, Lombardy
·
Since 1996
DOC Pharma is an Italian pharmaceutical manufacturer founded in 1996 and headquartered in Milan. The company employs 200–500 people and generated estimated revenue of €299 million in 2023. It specializes in branded and generic medicines across therapeutic areas, operates as Italy's equivalent medicines provider, and holds approximately 19% market share in the generic drug sector. The company's portfolio spans over 250 molecules and around 700 stock-keeping units distributed through Italian pharmacies.
DOC Generici at a glance
Revenue
$100-250M
Est. band
Employees
200-500
Founded
1996
Headquarters
Milan, Lombardy
Industries
Automotive
Electric Vehicles
Medical
Overview
DOC Pharma is an Italian pharmaceutical manufacturer founded in 1996 and headquartered in Milan. The company employs 200–500 people and generated estimated revenue of €299 million in 2023. It specializes in branded and generic medicines across therapeutic areas, operates as Italy's equivalent medicines provider, and holds approximately 19% market share in the generic drug sector. The company's portfolio spans over 250 molecules and around 700 stock-keeping units distributed through Italian pharmacies.
At a glance
Attribute | Detail |
|---|---|
Founded | 1996 |
Headquarters | Milan, Lombardy |
Employees | 200-500 |
Revenue | $100-250M (estimated) |
What DOC Generici makes
The company manufactures both refundable and non-refundable medications, including osteocarticular nutraceuticals and muscle relaxants, delivered through retail pharmacy networks across Italy.
Latest developments
2026-06-11 — Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a (globenewswire.com)
2026-05-29 — Pharmaceuticals: Doc Pharma Completes Acquisition of Riopan from Takeda (lamilano.it)
2026-04-09 — DOC Pharma acquisisce da Bayer S.P.A. il brand EMATONIL PLUS (docpharma.com)
2025-07-15 — A&O Shearman advises on DOC Pharma's EUR990 million senior secured notes and EUR150m revolving credit facility (aoshearman.com)
2025-06-26 — Latham Advises TPG and DOC Pharma on High Yield Bond and RCF (lw.com)
2025-03-12 — Bird & Bird con DOC Pharma nell’acquisizione di Geofarma (twobirds.com)
Company details
DOC Pharma ranks eighth among Italian pharmaceutical companies by value and holds a 19% market share in Italy's generic drug segment. DOC Generici was founded in 1996, has an estimated 200-500 employees, and is headquartered in Milan, Lombardy.
Frequently asked questions
What does DOC Generici do?
DOC Pharma is an Italian pharmaceutical manufacturer founded in 1996 and headquartered in Milan. The company employs 200–500 people and generated estimated revenue of €299 million in 2023. It specializes in branded and generic medicines across therapeutic areas, operates as Italy's equivalent medicines provider, and holds approximately 19% market share in the generic drug sector. The company's portfolio spans over 250 molecules and around 700 stock-keeping units distributed through Italian pharmacies.
Where is DOC Generici headquartered?
DOC Generici is headquartered in Milan, Lombardy (40 Via Filippo Turati, Milan, Lombardy, 20121).
When was DOC Generici founded?
DOC Generici was founded in 1996.
How big is DOC Generici?
DOC Generici has an estimated 200-500 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
